Trial · NCT02948842
Outcomes22
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Subjects With Complication After Treatment | 84 days | Only 3 subjects were treated with study treatment. Two subjects withdrew prior to receiving study treatment. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Patients Needing Further Intervention for Treatment of Urethral Stricture | 2 years | Only 3 subjects were treated with study treatment. Two subjects withdrew prior to receiving study treatment. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Subjects With Recurrence of Urethral Stricture | 2 years | Only 3 subjects were treated with study treatment. Two subjects withdrew prior to receiving study treatment. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Change From Baseline and 6 Weeks: American Urology Association Questionnaire Scores | 6 weeks | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 2 out of 3 treated subjects completed 6 weeks follow-up. | scores on a scale | MEAN |
| SECONDARY | Change From Baseline and 6 Months: American Urology Association Questionnaire Scores | 6 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 2 out of 3 treated subjects completed 6 months follow-up. | scores on a scale | MEAN |
| SECONDARY | Change From Baseline and 9 Months: American Urology Association Questionnaire Scores | 9 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 1 out of 3 treated subjects completed 9 months follow-up. | scores on a scale | NUMBER |
| SECONDARY | Change From Baseline and 12 Months: American Urology Association Questionnaire Scores | 12 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 1 out of 3 treated subjects completed 12 months follow-up. | scores on a scale | NUMBER |
| SECONDARY | Change From Baseline and 2 Years: American Urology Association Questionnaire Scores | 2 years | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 1 out of 3 treated subjects completed 2 years follow-up. | scores on a scale | NUMBER |
| SECONDARY | Time to Urethral Stricture Recurrence | 2 years | Only 3 subjects were treated with study treatment. Two subjects withdrew prior to receiving study treatment. None of the treated subjects had recurrence of urethral stricture. | ||
| SECONDARY | Time to Additional Intervention for Urethral Stricture | 2 years | Only 3 subjects were treated with study treatment. Two subjects withdrew prior to receiving study treatment. | months | MEDIAN |
| SECONDARY | Change From Baseline and 6 Weeks: Obstructive Voiding Dysfunction (Uroflow) | 6 weeks | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 2 out of 3 treated subjects completed 6 weeks follow-up. | mL/s | MEAN |
| SECONDARY | Change From Baseline and 6 Months: Obstructive Voiding Dysfunction (Uroflow) | 6 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 2 out of 3 treated subjects completed 6 months follow-up. | mL/s | MEAN |
| SECONDARY | Change From Baseline and 9 Months: Obstructive Voiding Dysfunction (Uroflow) | 9 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 1 out of 3 treated subjects completed 9 months follow-up. | mL/s | NUMBER |
| SECONDARY | Change From Baseline and 12 Months: Obstructive Voiding Dysfunction (Uroflow) | 12 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 1 out of 3 treated subjects completed 12 months follow-up. | mL/s | NUMBER |
| SECONDARY | Change From Baseline and 18 Months: Obstructive Voiding Dysfunction (Uroflow) | 18 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 1 out of 3 treated subjects completed 18 months follow-up. | mL/s | NUMBER |
| SECONDARY | Change From Baseline and 2 Years: Obstructive Voiding Dysfunction (Uroflow) | 2 years | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 1 out of 3 treated subjects completed 2 years follow-up. | mL/s | NUMBER |
| SECONDARY | Change From Baseline and 6 Weeks: Obstructive Voiding Dysfunction (Post-void Residual Measurements) | 6 weeks | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 2 out of 3 treated subjects completed 6 weeks follow-up. | mL | MEAN |
| SECONDARY | Change From Baseline and 6 Months: Obstructive Voiding Dysfunction (Post-void Residual Measurements) | 6 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 2 out of 3 treated subjects completed 6 months follow-up. | mL | MEAN |
| SECONDARY | Change From Baseline and 9 Months: Obstructive Voiding Dysfunction (Post-void Residual Measurements) | 9 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 1 out of 3 treated subjects completed 9 months follow-up. | mL | NUMBER |
| SECONDARY | Change From Baseline and 12 Months: Obstructive Voiding Dysfunction (Post-void Residual Measurements) | 12 months | Two subjects withdrew prior to receiving study treatment. Only 3 subjects were treated with study treatment. Only 1 out of 3 treated subjects completed 12 months follow-up. | mL | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02948842/outcomes